跳至主要内容
临床试验/NCT03152669
NCT03152669已完成不适用

The Extended Salford Lung Study ("Ex-SLS") Data Access Project

GlaxoSmithKline2 个研究点 分布在 1 个国家目标入组 1,183 人开始时间: 2018年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,183
试验地点
2
主要终点
Retrospective EMR data

研究概览

简要总结

The Salford Lung Study (SLS) subjects represent a group of COPD and asthma patients whose disease is extremely well-characterised over a short time period. Subjects in the SLS originally consented for information relevant to the study to be shared with the sponsor (GSK). These data were limited to three years prior to randomisation and the twelve-month interventional treatment period. Broadened access to patients' data would allow SLS subjects' entire disease journey to be researched, presenting a rare opportunity to improve scientific and clinical understanding of COPD/asthma disease risk, treatment and progression. This proposal seeks to collect additional subject-level data from SLS patients via their electronic medical records (encompassing past and future data for up to 10 years from the date of consent) and via a one-off patient questionnaire administered at the time of consent.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who were randomized to treatment in the original SLS studies
  • Subjects who are able to, and choose to, provide written consent for the additional information to be collected.

排除标准

  • Subjects who were lost to follow-up/moved away, withdrew consent or died during or subsequent to the original SLS studies.
  • Subjects considered (at the discretion of the investigator) as too ill to participate or without the mental capacity to provide informed consent.

研究组 & 干预措施

Chronic obstructive pulmonary disease

Subjects with COPD who were randomised to treatment in the original SLS

Asthma

Subjects with asthma who were randomised to treatment in the original SLS.

结局指标

主要结局

Retrospective EMR data

时间窗: Up to 10 years

All historical data from consent until the beginning of patients' electronic health records, encompassing all routinely-available electronic demographic and health-related data back to a patients' earliest available electronic record.

Risk factor questionnaire

时间窗: Up to 10 years

Historical demographic, COPD/asthma risk factor information and clinical data not routinely available. Collected via paper questionnaire.

Prospective EMR data

时间窗: Up to 10 years

Prospective longitudinal data, encompassing collection of future routinely-recorded electronic demographic and health-related data for a period of ten years from this consent or until a patient is either lost to follow up or at the time of their death.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验